, MD, MPH; for the CDC Prevention Epicenter Program IMPORTANCE Estimates from claims-based analyses suggest that the incidence of sepsis is increasing and mortality rates from sepsis are decreasing. However, estimates from claims data may lack clinical fidelity and can be affected by changing diagnosis and coding practices over time.
S epsis is a major public health problem. It is among the most expensive conditions treated in US hospitals and a leading cause of death. 1, 2 Numerous studies suggest that the incidence of sepsis is increasing over time, offsetting declining case-fatality rates. [3] [4] [5] [6] Despite its importance, reliably measuring sepsis incidence and trends is challenging. Most studies have used claims data, but increasing clinical awareness, changes in diagnosis and coding practices, and variable definitions have led to uncertainty about the accuracy of reported trends as well as marked heterogeneity in incidence and mortality rates. [7] [8] [9] [10] [11] Analyses in a limited set of hospitals using clinical data have also suggested that sepsis incidence and outcomes may be more stable than previously thought. [12] [13] [14] The increasing use of electronic health record (EHR) systems allows for the possibility of widespread sepsis surveillance using consistent clinical criteria for concurrent infection and organ dysfunction rather than claims data. In this study, Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) criteria were adapted for public health surveillance and optimized for applicability across different EHR systems. This definition was then applied to EHR data from a diverse set of hospitals to estimate US sepsis incidence and trends from [2009] [2010] [2011] [2012] [2013] [2014] and to compare with trends estimated from claims data.
Methods

Study Design, Data Sources, and Population
This was a retrospective cohort study using EHR and administrative data from 409 academic, community, and federal acute care hospitals gathered from 7 independent data sets: Brigham and Women's Hospital, Cerner HealthFacts, Emory Healthcare, Hospital Corporation of America, Institute for Health Metrics, University of Pittsburgh Medical Center health care system, and the Veterans Affairs (VA) hospital system (described further in eMethods 1 in the Supplement). These data sets were chosen to include a broad mix of hospitals that resemble all US acute care hospitals in terms of geographic mix, teaching status, and hospital size (eTable 1 in the Supplement).
The study included adults 20 years or older admitted as inpatients or under observation status or who died in the emergency department in calendar years [2009] [2010] [2011] [2012] [2013] [2014] . Fixed categories of race/ethnicity, as reported by patients in the EHR systems of each health care system, were included to characterize the generalizability of the study dataset and because of previously reported associations between race/ ethnicity and sepsis incidence and outcomes. 3 The study was approved with a waiver of informed consent by the institutional review boards at Harvard Pilgrim Health Care Institute, Partners HealthCare, University of Pittsburgh, Emory University, and Ann Arbor VA.
Sepsis Clinical Surveillance Definition
As per Sepsis-3 criteria, sepsis was defined as concurrent infection and organ dysfunction. 15, 16 Suspected infection criteria and the Sequential Organ Failure Assessment (SOFA) score, 17 however, were modified to facilitate widespread retrospective surveillance using routinely collected EHR data (Box). Presumed serious infections were defined as a blood culture draw and sustained administration of new antibiotics. Four or more antibiotic days, including at least 1 intravenous antibiotic, were required to identify those most likely to have serious infections and to eliminate patients treated empirically for 48 to 72 hours before culture results were obtained. Fewer than 4 antibiotic days were allowed if death or discharge to hospice or another acute care hospital occurred before 4 days elapsed. Sepsis criteria were met if patients had at least 1 concurrent acute organ dysfunction, defined by initiation of vasopressors or mechanical ventilation, elevated lactate level, or significant changes in baseline creatinine level, bilirubin level, or platelet count. The first antibiotic day and organ dysfunction were required to occur within ±2 calendar days of the blood culture draw. Organ dysfunction thresholds were selected to generally yield an increase in SOFA score of 2 or more points, to parallel Sepsis-3 criteria. The Glasgow Coma Scale score was not included because it was not measured in most patients and was variably assessed across hospitals. 18 Vital signs were also not included because they are not available in all EHRs and are susceptible to transient perturbations and measurement errors. Although not part of the SOFA score, lactate levels of 2.0 mmol/L or greater were included for the analysis of sepsis incidence, outcomes, and clinical characteristics in 2014, given the central role of lactate levels in identifying and risk stratifying sepsis. 19, 20 As discussed below, however, the lactate criterion was excluded from the primary trends analysis because lactate testing rates are rapidly increasing over time and may thus introduce ascertainment bias. 21 Sepsis was defined as hospital onset (vs present on admission) if infection and organ dysfunction criteria first occurred on or after hospital day 3. Baseline laboratory values for creatinine, bilirubin, and platelets were estimated using the best value during hospitalization for infection present on admission, or best values within ±2 days of the blood culture for hospital-onset infection. The entire hospitalization was considered a single case of sepsis if surveillance criteria were met multiple times. Septic shock was defined as presumed serious infection concurrent with vasopressors and serum lactate level 2.0 mmol/L or greater.
Blood culture draws were used to anchor the primary definition because they are an important marker of suspected sepsis and are relatively simple to identify in EHRs. However, a sensitivity analysis was performed using any clinical culture as a broader definition of presumed infection (eAppendix C in the Supplement). These definitions were developed through consensus discussions among the investigative team, informed by prior work using similar approaches. 12, 14, 16, 22 Implementation Case-finding code was created in SAS and SQL and distributed to partners to execute locally against their EHR data arrayed according to a common data specification (detailed description provided in eAppendices A-F in the Supplement). Patient comorbidities were derived from International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes using the Charlson method. 23 
Validation Using Medical Record Reviews
Study physicians reviewed full text medical records from 510 randomly selected hospitalizations, stratified into those that did and did not meet EHR sepsis surveillance criteria. These hospitalizations were drawn from 3 academic centers and 2 community hospitals in Massachusetts and Georgia. Hospitalizations were classified by reviewers as sepsis-positive if there was definite or possible infection and an increase in SOFA score by 2 or more points from baseline as a result of infection, as per Sepsis-3 criteria. 15 "Definite infection" required positive cultures or radiography and a compatible clinical syndrome. "Possible infection" required documentation that the medical team presumed the patient's illness was due to infection, treated for infection, and did not find an alternative etiology. Reviewers were blinded to whether cases were flagged by EHR surveillance criteria and patients' ICD-9-CM codes (additional details in eMethods 2 in the Supplement).
Trends
Annual trends in sepsis incidence and in-hospital mortality from 2009-2014 were calculated in the subset of hospitals with historical data (at least 84 hospitals per year) (eTable 2 in the Supplement). In light of rising rates of hospice utilization nationwide, 24 the combined outcome of in-hospital death or discharge to hospice was also examined to obtain a more complete picture of trends in sepsis outcomes. An a priori decision was made to exclude the lactate criterion when assessing whether sepsis incidence and outcomes are changing over time. This was done in light of steady increases in lactate testing rates, which might create ascertainment bias and inflate perceived changes in sepsis incidence. 21, 25 However, a secondary analysis was performed with the lactate criterion to test this hypothesis. We also applied 2 claims-based definitions: "explicit" ICD-9-CM codes for severe sepsis (995.92) and septic shock (785.52) and an "implicit" method requiring at least 1 infection code and 1 organ dysfunction code (Angus method) or explicit codes for severe sepsis or septic shock. 26, 27 To examine whether recognition and coding for sepsis is increasing, we calculated the annual proportion of hospitalizations flagged by the primary EHR surveillance definition that also received sepsis codes.
Statistical Analyses
To account for different hospitals contributing data in different years, 2009-2014 trends were modeled using generalized estimating equations to fit Poisson regression models, adjusting for hospital characteristics (institution, region, teaching status, bed count, and annual admissions) and case mix (median age of hospitalized patients, sex and race/ethnicity distributions, and proportion of intensive care unit [ICU] vs total admissions). Generalized estimating equations were used to account for correlations in the data over time as well as hospital-level clustering. b Vasopressors and mechanical ventilation are considered to be "initiated"
during the ±2-day period surrounding the day of the blood culture draw if there were no vasopressors or mechanical ventilation administered on the prior calendar day.
c For presumed infection present on admission (blood culture day or first QAD occurring on hospital day 1 or 2), baseline laboratory values are defined as the best values during hospitalization. For hospital-onset infection (blood culture day and first QAD occurring on hospital day Ն3), baseline laboratory values are defined as the best values during the ±2-day period surrounding the day of the blood culture draw.
Adjusted rates for 2009-2013 were generated by creating binary indicators for each year in the model, with 2014 as the reference year. The overall change from 2009 to 2014 was summarized as the exponentiated slope of the line between these 2 years on the log scale. All percentages were presented as relative annual changes. VA hospitals were excluded from trends analyses because only data from 2014 were available. The national weighted incidence and mortality of sepsis among hospitalized adults in 2014 was estimated by projecting study hospital case counts into stratifications of US hospitals by region, size, and teaching status (eMethods 3 in the Supplement).
Missing laboratory data for organ dysfunction calculations were assumed to be normal. Multiple imputation was not performed because missing data were presumed to be missing owing to clinical decisions not to order certain tests rather than missing at random. Data completeness was assessed by inspecting each data element required for the EHR sepsis definition on a hospital-by-hospital-level basis and aggregate rates of organ dysfunction and sepsis incidence and outcomes across each dataset (eFigures 1 and 2 in the Supplement).
Continuous variables were expressed as means. Nonnormally distributed variables were expressed as medians of the medians among the 7 datasets. Analyses were conducted using SAS version 9.3 (SAS Institute) and R version 3.3.1 (http://www.r-project.org). For all analyses, P < .05 (2-sided) was considered statistically significant.
Results
Sepsis Incidence, Clinical Characteristics, and Outcomes in 2014
The 2014 study cohort included 2 901 019 adult encounters in 409 hospitals, representing approximately 10% of all US adult hospitalizations. Study hospitals' characteristics are reported in Table 1 . There were 423 758 patients with presumed serious infection (14.6% incidence [95% CI, 14.6% to 14.7%), of which 32 574 (7.7% [95% CI, 7.6% to 7.8%]) died in the hospital. There were 173 690 patients with sepsis (overall hospital incidence, 6.0% [95% CI, 6.0% to 6.0%]). The clinical characteristics of patients with sepsis are reported in were present on admission. Among hospitals (n = 280) for which culture results were available, 17.2% (95% CI, 17.0% to 17.4%) of patients with sepsis had positive blood cultures.
Of the 173 690 patients with sepsis in study hospitals in 2014, 94 956 (54.7%) required ICU care during hospitalization, 27 502 (15.8%) had septic shock, 26 061 (15.0%) died in the hospital, and 10 731 (6.2%) were discharged to hospice (Table 2 ). Median ICU length of stay was 5 days (range, 2-6). Median hospital length of stay was 10 days (range, [8] [9] [10] [11] [12] . Hospital mortality was 25.5% among patients with hospitalonset sepsis vs 13.4% for patients with sepsis present on admission (difference, 12.1% [95% CI, 11.5% to 12.7%]; P < .001). Sepsis was present during hospitalization in 34.7% of the 75 079 study patients who died in the hospital in 2014. When adjusting for hospital region, size, and teaching status, the estimated national weighted incidence of sepsis was 5.9% (95% CI, 5.5% to 6.3%), and the in-hospital mortality rate was 15.6% (95% CI, 14.8% to 16.5%) (strata-specific counts reported in eTable 3 in the Supplement). Mortality rates for septic patients were higher for older patients, men, teaching hospitals, and larger hospitals (eTable 4 in the Supplement).
The distribution of organ dysfunctions, and their associated mortality rates, are shown in Figure 1 . Approximately 50% of patients with sepsis met at least 2 criteria for acute organ dysfunction. Among the 13 Sepsis-3 cases missed by EHR criteria, the most common reason was hypoxemia causing an increase in SOFA score of 2 or more points without need for mechanical ventilation (eTable 6 in the Supplement). None of these 13 patients died. There were 57 false-positives flagged by EHR criteria; most were because clinicians initially suspected infection but medical record reviewers ultimately deemed no infection was present or because patients' organ dysfunction did not increase SOFA score by 2 or more points (typically patients with elevated lactate levels alone) (eTable 7 in the Supplement). If sepsis was defined as clinically suspected infection with organ dysfunction at the thresholds specified by EHR criteria, PPV was 87.9% (95% CI, 82.7% to 92.0%).
Trends From 2009-2014
The trends analysis included 7 801 624 hospitalizations between 2009-2014 ( Figure 2) . The annual incidence of sepsis (without the lactate criterion) was stable (+0.6% relative change/y [95% CI, −2.3% to 3.5%], P = .67). In-hospital mortality decreased (−3.3%/y [95% CI, −5.6% to −1.0%], P =.004), but there was no significant change in the combined outcome of death or discharge to hospice (−1.3%/y [95% CI, −3.2% to 0.6%], P = .19). Patients with sepsis were increasingly discharged to hospice over time (+6.3%/y [95% CI, 1.1% to 11.6%], P = .02).
When including lactate as a criterion, sepsis incidence increased (+3.5%/y [95% CI, 0.7% to 6.4%], P = .02), mortality decreased (−5.0%/y [95% CI, −7.3% to −2.7%], P < .001), and death or discharge to hospice decreased (−2.0%/y [95% CI, −3.8% to −0.2%], P = .03).
Sepsis incidence using explicit severe sepsis/septic shock codes increased significantly (+10.3%/y [95% CI, 7.2% to 13.3%], P < .001), as did sepsis/septic shock defined using explicit codes or implicit codes (+7.3%/y [95% CI, 5.0% to 9.5%], P < .001). Mortality declined using explicit codes (−7.0% [95% CI, −8.8% to −5.2%], P < .001) and explicit or implicit codes combined (−6.6%/y [95% CI, −8.3% to −4.8%], P < .001). The combined outcome of death or discharge to hospice also decreased with explicit codes (−4.5% [95% CI, −6.1% to −2.8%], P < .001) and with explicit or implicit codes combined (−3.6% [95% CI, −4.9% to −2.3%], P < .001).
Among patients meeting EHR clinical criteria for sepsis, the proportion who received explicit sepsis codes increased from 24.9% in 2009 to 30.5% in 2014 (difference, 5.6% [95% 
Sensitivity Analyses
Sensitivity analyses restricted to hospitals that reported data each year from 2009-2014 yielded similar differences in EHR-based vs claims-based trends (eFigure 3 in the Supplement). When any clinical culture was used to indicate presumed infection rather than blood cultures alone, sepsis incidence rates in 2014 were higher (7.1% vs 6.0%; difference, 1.1% [95% CI, 1.0% to 1.1%]; P < .001) and mortality rates lower (14.0% vs 15.0%; difference, 1.0% [95% CI, 0.8% to 1.2%]; P < .001). Clinical characteristics and trends were similar (eTables 8-9 in the Supplement).
Discussion
In this retrospective analysis of more than 2.9 million adults admitted to 409 US hospitals in 2014, clinical indicators of sepsis were present in 6% of hospitalized patients, of whom 21% died in the hospital or were discharged to hospice. Sepsis was present in 35% of all hospitalizations that culminated in death.
In contrast to claims-based analyses, sepsis incidence rates using clinical data were stable from 2009-2014; in-hospital mortality rates declined, but there was no significant change in the combined outcome of death or discharge to hospice. Reliable sepsis surveillance is essential given its high burden, the proliferation of treatment and prevention initiatives, and new national sepsis quality measures. Identifying sepsis using consistent clinical criteria through EHR data, rather than relying on explicit clinical diagnoses or hospital coders, enhances confidence in sepsis estimates because clinicians underrecognize sepsis and vary widely in their knowledge and application of sepsis definitions. [28] [29] [30] Hospitals also vary significantly in how they assign codes for infection and organ dysfunction, and the presence of both of these codes at discharge does not guarantee that they occurred concurrently. [31] [32] [33] EHR-based criteria were more sensitive than explicit sepsis codes on medical record review, with comparable PPV; EHRbased criteria had similar sensitivity to implicit or explicit codes combined but higher PPV. EHR-based clinical surveillance also provides more credible estimates of sepsis trends compared with claims, which can be biased by changing diagnosis and coding practices over time. 9, 10, 13, 34 Among patients with sepsis identified using EHR clinical criteria, there was an increase over time in the proportion assigned explicit and implicit sepsis codes, presumably reflecting ongoing efforts to improve sepsis awareness, documentation, and coding. Improving sepsis recognition, including less severe cases, likely accounts for the difference in clinical vs claims-based incidence trends as well as the greater mortality decline seen with claims. The apparent improvement in sepsis-associated mortality was also nullified when also considering discharge to hospice, underscoring the need to consider temporal changes in end-of-life care patterns when assessing trends in clinical outcomes. 24 When including elevated lactate levels in the surveillance definition, mild increases in sepsis incidence and decreases in mortality or discharge to hospice were observed. This likely reflects increasingly aggressive lactate testing over time and identification of progressively less ill patients with sepsis, paralleling the increase in sepsis awareness and coding. 21, 25 Thus, although lactate surveillance can be useful for identifying sepsis A, Number of sepsis cases with each organ dysfunction and associated in-hospital deaths were n = 49 400 (16 715 deaths) for vasopressor initiation; n = 45 088 (14 290 deaths) for initiation of mechanical ventilation; n = 92 779 (18 345 deaths) for hyperlactatemia (serum lactate level Ն2.0 mmol/L); n = 75 553 (9664 deaths) for acute kidney injury (doubling in baseline creatinine level or decrease in estimated glomerular filtration rate by Ն50%); n = 26 083 (3717 deaths) for hepatic injury (doubling in baseline total bilirubin level to Ն2.0 mg/dL); n = 21 830 (4869 deaths) for thrombocytopenia (decrease in baseline platelet count by Ն50%, with baseline platelets >100 cells/μL). Further details on organ dysfunction criteria are described in the Box. Total number of sepsis encounters, 173 690. B, Number of sepsis cases meeting the specified number of organ dysfunction criteria and associated in-hospital deaths were n = 173 690 (26 061 deaths) for 1 or more organ dysfunction criteria; n = 88 248 (20 687 deaths) for 2 or more organ dysfunction criteria; n = 50 466 (16 506 deaths) for 3 or more organ dysfunction criteria; and n = 29 161 (11 725 deaths) for 4 or more organ dysfunction criteria. Number of organ dysfunction criteria includes different organ dysfunctions that may have occurred at separate times during hospitalization if surveillance criteria were met more than once.
cases at a single point, it risks generating misleading impressions of changes in sepsis incidence and outcomes over time.
Ongoing improvements in sepsis coding suggest that claims may eventually reach the accuracy of EHR data. However, the variability of claims between hospitals and their susceptibility to shifting policy and reimbursement incentives limits their use to compare hospitals or assess trends-limitations particularly important in the new era of sepsis quality measures and regulations. 9, 35 Surveillance experience from other domains, such as health care-associated infections, speak to the risk of reimbursement policies changing coding practices and hence perceived rates that do not reflect true changes in infection rates.
36-38
The national weighted sepsis incidence of 5.9% among hospitalized patients and in-hospital mortality of 15.6% estimated in this study would translate into approximately 1.7 million US adult sepsis hospitalizations and 270 000 deaths in 2014. This falls within the wide incidence range of 900 000 to 3.1 million previously estimated using 4 different claims-based definitions. 7 The observed mortality rate exceeds the 10% mortality reported in the Sepsis-3 derivation and validation studies. 16 This may reflect the more stringent definition of presumed infection (requiring blood cultures and ≥4 days of antibiotics rather than a single dose) and SOFA score adaptations.
Strengths and Limitations
Strengths of the current study include the use of detailed clinical data from a large number of diverse hospitals that together account for approximately 10% of all US acute care hospitalizations in 2014. The data sets came from unrelated hospital networks, limiting the possibility of bias from idiosyncratic clinical, diagnosis, or coding patterns. A sensitivity analysis using a broader definition of presumed infection demonstrated relatively little change in sepsis incidence and outcomes and no difference in trends, supporting the robustness of the primary definition. This study also has several limitations. First, EHR-based surveillance may be affected by differences in clinical practice between clinicians and hospitals as well as changes over time. This may be most evident with rising rates of lactate testing, but earlier initiation of vasopressors for hypotension and increasing use of noninvasive ventilation and high-flow nasal cannulas for respiratory failure could also affect estimates. The partial dependence on clinician-initiated interventions to measure organ dysfunction, however, is also a limitation of the SOFA score and thus the Sepsis-3 criteria.
Second, only adults in US acute care hospitals were included; future studies should address sepsis in neonates and children, as well as consider ways to identify sepsis outside hospitals and in countries without widespread EHR systems.
Third, not all hospitals contributed data each year for trends analyses. However, regression models were used to adjust for hospital-level differences.
Fourth, the study did not directly ascertain sepsis mortality that occurs after hospital discharge.
Fifth, medical record reviews were only conducted on a fraction of the study cohort. Cases were drawn from both academic and community hospitals, but they still may not be representative of all hospitals. Sixth, the study dataset might not be representative of national data. However, study hospitals had characteristics similar to those of US hospitals overall and represented a substantial fraction of total admissions nationwide.
Seventh, medical record reviews suggest that EHR-based surveillance may miss up to 30% of patients with sepsis while misclassifying another 30%. Quantifying the accuracy of sepsis criteria is elusive, however, because there is no true gold standard for sepsis. 30, 39, 40 Recognizing this problem, the Sepsis-3 task force developed and validated criteria based on associations with adverse outcomes. 15, 16 The EHR surveillance definition in this study carried high mortality rates (15%) compared with all encounters with presumed infection (8%), and mortality increased with increasing numbers of dysfunctional organs. On medical record reviews, the Sepsis-3 cases missed by EHR surveillance involved mild organ dysfunction, such as hypoxemia without need for mechanical ventilation, and no patients in that group died. False-positives were most often attributable to reviewers adjudicating the absence of infection despite patients receiving blood culture draws and antibiotics, or a noninfectious cause of organ dysfunction. When sepsis was defined as organ dysfunction concurrent with clinically suspected infection (as is common in practice), PPV of the surveillance definition increased to 88%.
Eighth, neither Sepsis-3 criteria nor EHR-based clinical surveillance can solve the challenge that clinicians routinely face in deciding whether their patient is infected and whether organ dysfunction is due to infection. Instead, EHR surveillance provides a consistent gauge to estimate sepsis incidence and outcomes using readily available, objective clinical data. This method cannot help clinicians identify sepsis at the bedside since it is retrospective, but it may be useful for public health surveillance, hospital evaluation, and assessing the effects of quality improvement efforts. EHR-based surveillance may further support these objectives by facilitating granular evaluation of the timing of sepsis onset and interventions.
Conclusions
In clinical data from 409 hospitals, sepsis was present in 6% of adult hospitalizations, and in contrast to claims-based analyses, neither the incidence of sepsis nor the combined outcome of death or discharge to hospice changed significantly between 2009-2014. The findings also suggest that EHRbased clinical data provide more objective estimates than claims-based data for sepsis surveillance. This supplementary material has been provided by the authors to give readers additional information about their work.
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I. SUPPLEMENTAL METHODS, TABLES, AND FIGURES eMethods 1. Healthcare Systems / Datasets Used in Study
The institutions involved in our study included a broad array of academic, community, and federal hospitals with diverse electronic health record (EHR) systems. For this study, acute care hospitals were included, while psychiatric, rehabilitation, and children's hospitals were excluded. Each dataset is described below.
Hospital Corporation of America (HCA):
HCA is the largest for-profit healthcare system in the U.S., with 165 hospitals spread across 20 different states. The hospitals mainly consist of urban and suburban community medical centers but also include several complex tertiary referral and academic medical centers. From geographic, demographic, and socioeconomic standpoints, this population is representative of the U.S. population as a whole. 1 HCA hospitals primarily use the Meditech EHR system. Comprehensive clinical data is stored in a centralized data warehouse and undergoes lineitem validation until >99% accuracy is achieved. This data warehouse has been used in the analysis of large cluster randomized trials, quality improvement initiatives, and other retrospective studies. [2] [3] [4] [5] [6] [7] For this study, HCA provided complete data from 137 acute care hospitals for 2013 and 2014. 2. Veterans Affairs (VA) Hospitals: the VA is the largest integrated health system in the U.S and includes 130 hospitals, including at least one in every state. The VA has long been a national leader in the adoption of EHRs and has used a homegrown integrated EHR system since 1999. 8 Data from the VA EHR system has been used in multiple retrospective studies, including in the validation of the Sepsis-3 clinical criteria. [9] [10] [11] [12] For this study, the VA provided complete data from 129 hospitals for 2014.
University of Pittsburgh Medical Center (UPMC) System: UPMC includes academic and
community hospitals distributed throughout western Pennsylvania that collectively provide care for over 400,000 patients per year and utilize the Cerner EHR system. This dataset served as the primary dataset for derivation of the Sepsis-3 clinical criteria. 12 For this study, UPMC provided data from 11 hospitals for 2010-2014. The data did not overlap with the Cerner HealthFacts dataset. 4. Cerner HealthFacts® Dataset: rather than a single integrated healthcare system, HealthFacts is a de-identified patient database that receives granular clinical data from a subset of hospitals that use the Cerner EHR system. This dataset was first launched in 2000 and has been utilized in several retrospective studies spanning a range of different conditions. [13] [14] [15] [16] [17] [18] [19] For this study, we included 78 hospitals with complete data in 2014. A smaller subset of hospitals (at least 41 hospitals per year) provided data from 2009-2013.
Institute for Health Metrics (IHM):
IHM is a non-profit organization that assists more than 100 hospitals across 30 states using the Meditech EHR system to extract and aggregate their electronic clinical data to support regulatory, reporting, quality improvement, and research initiatives. 20, 21 The network primarily includes community hospitals with an average size of 160 beds. For this study, 49 hospitals provided one-half year of data for hospitalizations spanning July-December 2014. A subset of hospitals (at least 27 hospitals per year) provided data from 2009-2013. 6. Brigham and Women's Hospital (BWH): this academic medical center in Boston, Massachusetts provides inpatient care for over 50,000 patients per year. During the years of this study, BWH used a homegrown EHR system and stored detailed electronic clinical data from 2002 onwards in a clinical data warehouse (the Partners Research Patient Data Repository). 22 Data from this repository has been used for numerous research studies, including several studies of sepsis epidemiology and trends. [23] [24] [25] [26] 7. Emory Healthcare: Emory Healthcare is the largest healthcare system in the state of Georgia and uses a Cerner EHR system. It has stored data in the Emory Clinical Data Warehouse since 1993 and has supported analysis of several quality improvement initiatives. 27, 28 For this study, Emory Healthcare provided complete data from 4 hospitals for 2010-2014. The data did not overlap with the Cerner HealthFacts dataset.
eMethods 2. Validation of EHR Surveillance Definition by Medical Record Reviews
In the Emory Healthcare system, one internist (R.D.) and one infectious disease physician (L.E.) reviewed a total of 310 hospitalizations using a standardized data abstraction tool in REDCap. 29 110 cases were drawn from the surveillance definition-positive cohort, 110 were drawn from the definitionnegative but presumed infection-positive cohort, and 90 were drawn from the definition-negative/infectionnegative cohort. Reviewers were blinded to results of the EHR surveillance definition as well as discharge diagnosis codes. The initial 10 charts were reviewed together by the two reviewers; subsequently, 30 charts were reviewed independently and assessed for concordance. Agreement amongst those cases was good (kappa 0.73). The 4 cases where reviewers disagreed were excluded, yielding a total of 306 cases for analysis.
At Brigham and Women's Hospital (BWH), one intensivist (C.R.) reviewed 200 hospitalizations (100 surveillance definition-positive and 100 definition-negative, regardless of whether or not infection criteria was met), blinded to results of the surveillance definition and discharge diagnosis codes, using the same REDCap tool. This intensivist had previously been demonstrated to have good interrater reliability (kappa 0.80) compared to a second intensivist when adjudicating the presence of sepsis on medical record reviews in this dataset. 26 Hospitalizations were classified as sepsis if there was either definite (i.e., positive cultures or radiography and compatible syndrome) or possible infection (i.e., infection presumed and treated by the medical team and no definitive alternate etiology found), and if organ dysfunction was present (with a rise in Sequential Organ Failure Assessment Score by ≥2 from baseline) and was felt to be related to infection. Baseline SOFA scores were determined by the reviewer based on an array of available data in the medical records, estimating the degree of organ dysfunction prior to infection onset (if infection occurred during hospitalization) or at baseline health (if infection was present-on-admission). The EHR surveillance definition was then compared to the results of the medical record reviews. To calculate sensitivity, specificity, positive predictive value, and negative predictive value, the proportions were extrapolated back to the entire hospitalized population at the BWH and Emory hospitals. 10,000 bootstrapped samples were then created to calculate percentile-based confidence intervals for sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) using R version 3.3.1 (r-project.org). An identical method was used to calculate performance of claims-based definitions (explicit severe sepsis or septic shock codes, and the combination of implicit codes for infection and organ dysfunction [Angus method] 30,31 or explicit severe sepsis / septic shock codes). Sensitivity for EHR vs claims-based definitions was compared on the pooled number of sepsispositive reviewed charts (n=163) using McNemar's test of paired proportions. The PPV for EHR vs claims-based definitions was compared by using a multinomial-based Wald statistic to test for equality. The test statistic in this paired study design was based on a bootstrapped estimate of the variance-covariance matrix, and accounts for correlations that arise from applying each surveillance definition to the same charts. 32 The results are summarized in eTable 5.
eMethods 3. National Weighting Methodology for Sepsis Incidence and Mortality
In order to obtain a weighted estimate of sepsis incidence and mortality in all U.S. hospitals, study hospitals and American Hospital Association (AHA) acute care hospitals were stratified by bed size (large -≥500 beds, medium -200-499 beds, and small -<200 beds), teaching vs nonteaching status (as defined by the Accreditation Council for Graduate Medical Education), and U.S. region (Northeast, South, West, and Midwest). Hospitals in the AHA database were excluded if they were rehabilitation, pediatric, or psychiatric hospitals, or had zero general medical or surgical beds.
To account for the fact that the 49 Institute of Health Metrics (IHM) hospitals only had data from July-December 2014, sepsis incidence and death rates for January-June 2014 were imputed by averaging January-June sepsis incidence and mortality rates from IHM hospitals in 2013 and 2015. The total number of hospital admissions for January-June 2014 were also imputed by averaging the overall hospital admission rates in January-June vs July-December from calendar years 2013 and 2015.
The weighted sepsis incidence was obtained by a weighted mean of stratum specific sepsis incidence, estimated from study hospitals, with weights proportional to the number of AHA adult admissions in the stratum (eTable 3 below). The number of adult admissions in each hospital was not available in the AHA database; thus, to project the number of adult sepsis cases in each stratum, we multiplied the ratio of adult to total (adult and pediatric) admissions in our study hospitals against the AHA estimate for total admissions in each stratum. The weighted mortality rate was calculated similarly. Confidence intervals were generated based on the variance.
Standard errors and confidence intervals for the estimates were generated based on the binomial distributions and accounting for both within-and between-hospital variations in sepsis and mortality rates. Abbreviations: Regions -NE = northeast, MW = Midwest, S = south, W = west; Size -L = large (≥500 beds), M = medium (200-499 beds), S = Small (<200 beds); Teaching Status -N = nonteaching, T = teaching hospital. AHA = American Hospital Association.
a The Midwest Large Nonteaching hospital stratum was combined with the Midwest Medium Non-teaching hospital stratum because there was only 1 AHA hospital in that stratum. The West Large Nonteaching hospital stratum was combined with the West Medium Non-teaching hospital stratum for the same reason.
. Abbreviations: NPV = negative predictive value, PPV = positive predictive value. Numbers in brackets refer to the 95% confidence intervals.
eTable 6. EHR Sepsis Definition vs Sepsis-3 by Chart Reviews: False Negatives
Reasons for EHR Surveillance False Negatives vs Sepsis-3 Chart Reviews False Negatives (Total N=13) Rise in SOFA score by ≥2 points but no EHR organ dysfunction a Hypoxemia without requiring mechanical ventilation Hypotension without requiring vasopressors Abnormal Glasgow Coma Scale SOFA by creatinine but no doubling in baseline creatinine SOFA by bilirubin but not bilirubin >2.0 mg/dL with doubling from baseline SOFA by thrombocytopenia but platelets not <100 cells/µL with >50% decrease from baseline No blood cultures drawn 2 Rise in SOFA score by ≥2 points related to infection occurred outside of the +/-2 day EHR surveillance window around blood culture day b 1 a Five cases had multiple contributors to a total rise in SOFA score by ≥2 points: one patient had hypoxemia not requiring mechanical ventilation (1 SOFA point) + hypotension not requiring vasopressors (1 SOFA point); one patient had hypoxemia not requiring mechanical ventilation (1 SOFA point) + abnormal Glasgow Coma Scale (1 SOFA point); two patients had abnormal creatinine and bilirubin contributing 1 SOFA point each; and one patient had abnormal creatinine and thrombocytopenia contributing 1 SOFA point each. The case that occurred outside the ±2 day surveillance window developed a rise in creatinine and hypoxemic respiratory failure leading to a rise in SOFA score by ≥2 points. a The various reasons why EHR organ dysfunction criteria were not caused by infection add up to more than the total N=20 in that category because 2 cases had multiple non-sepsis related organ dysfunctions. These included a patient who had a doubling in serum creatinine and mechanical ventilation unrelated to infection; and a patient with doubling in serum creatinine and decline in platelet count by >50% to <100 unrelated to infection.
b One patient had both lactate ≥2.0 and doubling in serum creatinine, without a corresponding rise in SOFA score by ≥2 points. 
eTable 9. Trends for Sepsis Defined by Clinical Cultures
This table represents the adjusted trends in incidence, in-hospital mortality, and the combined outcome of in-hospital death or discharge to hospice, for patients who met EHR sepsis criteria when presumed infection was defined by any clinical culture test rather than blood cultures alone. "Sepsis With Lactate" refers to the surveillance definition that included elevate lactate as a criterion for organ dysfunction, while "Sepsis Without Lactate" excluded the lactate criterion. As with the trend analyses for the blood culturebased EHR surveillance definitions, VA hospitals were excluded. 
Sepsis
. Overall Sepsis Rates and Outcomes in Each Study Dataset in 2014
Each data point represents the mean rate of the specified variable in one of the 7 study datasets. The "presumed infection cases with sepsis" refers to the proportion of patients meeting presumed infection criteria (blood culture + 4 qualifying antibiotic days) that had ≥1 concurrent organ dysfunction criteria. Bars represent the 95% confidence intervals. The datasets are presented in no specific order. Each data point represents the mean rate of the specified organ dysfunction criteria amongst all sepsis cases (defined using blood cultures) in one of the 7 study datasets. Bars represent the 95% confidence intervals. The datasets are presented in no specific order.
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Thresholds for laboratory-based organ dysfunction criteria are as follows (as described in Box 1 in the main manuscript): hyperlactatemia -serum lactate ≥2.0 mmol/L; acute kidney injury -doubling in baseline creatinine or decrease in estimated glomerular filtration rate by ≥50%; thrombocytopenia -decrease in baseline platelets by ≥50% with baseline platelets >100 cells/µL; hepatic injury -doubling in baseline total bilirubin to ≥2.0 mg/dL. Determine if the patient had hospital-onset infection vs infection present-on-admission.
• "Hospital-Onset Infection" (vs "Present-on-Admission" Infection) -requires that the Blood Culture Day and First QAD occur on or after day 3 of admission (where day 1 = day of admission). In this case, baseline creatinine or bilirubin = lowest value during +/-2 day window period (around the Blood Culture Day), and baseline eGFR and platelet count = highest value during +/-2 day window period.
• "Present-on-Admission Infection" -requires that the Blood Culture Day OR First QAD occur on day 1 or 2. In this case, baseline creatinine or bilirubin = lowest value during hospitalization, and baseline eGFR and platelet count = highest during hospitalization.
PRESUMED SERIOUS INFECTION
Blood Culture obtained
• The blood culture day is the center of a +/-2 day surveillance window period. Sensitivity analyses were also performed using a broader set of clinical cultures (see eAppendix C).
• Multiple windows during a hospitalization are possible. The surveillance schedule utilizes a "sliding window" that allows for overlap if multiple blood cultures are drawn in short period of time. 2. ≥4 "Qualifying Antibiotic Days" (QAD) -starting within +/-2 days of BC Day:
• First QAD = first day in +/-2 day window period that patient receives a "new antibiotic" ("new" = not given in the prior 2 calendar days. "New" treats PO and IV formulations of an antibiotic the same way, EXCEPT for vancomycin). IV and IM antibiotics are treated as equivalents. See eAppendix B for list of antibiotics that count as potential QADs.
• Subsequent QADs can be the same antibiotic, or different antibiotics as long as first dose of each antibiotic in the sequence is "new" (i.e., not given in prior 2 calendar days). • There must be at least one new parenteral (IV/IM) antibiotic within the +/-2 day window period.
• For an inpatient, if death, discharge to another hospital, or discharge to hospice occurs before 4 QADs have elapsed, then the patient the patient can qualify for presumed infection with <4 QADs so long as they have consecutive QADs until day of, or 1 day prior to, death or discharge . For a patient only seen in the ED or ED observation unit, a QAD is required each day until day of, or 1 day prior to, death. ACUTE ORGAN DYSFUNCTION 3. Any one of the following, within +/-2 days of Blood Culture:
• • Blood Culture, First QAD, and all Organ Dysfunction Criteria. In other words, the "Sepsis Onset
Day" is the earliest day in the window period where the blood culture, first QAD, or organ dysfunction criteria is met. Hospital-onset sepsis requires sepsis onset day to be day 3 or greater.
• A sepsis case should be defined as Present-on-Admission Sepsis if any one of (Blood Culture Day, First QAD, or any Organ Dysfunction criteria) occurs on days 1 or 2.
When using blood culture, antibiotic, laboratory, or vasopressor / mechanical vent data to calculate sepsis cases, data from day -1 and day 0 (i.e. 2 days prior to admission) should be allowed to qualify for sepsis. (This is to account for data that might result from care in the emergency department prior to admission.)
eAppendix B. Medications Used in Study (Antibiotics and Vasopressors)
For purposes of case-finding criteria, the antibiotics were divided into parenteral (IV) and oral (PO) antibiotics. "Antibiotics" include antibacterial, antifungal, and antiviral agents. All PO and IV antibiotics were considered identical for purposes of determining whether an antibiotic is "new" or not (meaning that a switch from IV to PO or vice versa does not count as a "new antibiotic.") The one exception is IV vs PO Vancomycin (meaning that a switch from IV to PO vancomycin, or initiation of PO vancomycin while still on IV vancomycin, and vice versa, all count as "new" antibiotics). Intramuscular (IM) antibiotics were treated equivalently as IV antibiotics. The generic names of the antimicrobials included are listed below. The five vasopressors of interest were Norepinephrine, Epinephrine, Dopamine, Vasopressin, and Phenylephrine. We only included intravenous administrations of vasopressors, and excluded vasopressors that were clearly single bolus injections rather than continuous infusions.
ANTIBIOTICS
eAppendix C. Definitions of Blood Cultures and Clinical Cultures
For the primary EHR surveillance definition, blood cultures were used as the center of the surveillance window (regardless of blood culture results). We included bacterial (aerobic and/or anaerobic), acid-fast bacilli (AFB), and fungal blood cultures. Blood cultures for specific viruses (e.g., cytomegalovirus) were excluded.
For a sensitivity analysis, a broader range of clinical cultures were used to define suspected infection, detailed below. Growth of any organism from a blood culture was considered to be positive, with the exception of the following common skin contaminants: 
TESTS INCLUDED AS "CLINICAL CULTURES
• Coagulase
